In addition, there are other known reversion therapeutic targets, TPT1/TCTP and SETDB1 from previous studies.[2, 3, 43] Although these studies do not provide Boolean network models, we can still suggest that the cancer reversion induced by inhibiting each target is comparable with the normalization of IO relationship. This evidence concerns the gene TPT1 and cancer.